Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,880.00-0.09%ETH$2,285.68+0.72%GOLD$3,909.30+0.27%OIL$99.55-4.39%
Smart Investors Daily
SID Premium
PG

NASDAQ · PGNY

Progyny, Inc.

Healthcare · Medical - Healthcare Information Services

$29.19

Up+$0.79 (+2.78%)

Updated Nov 2, 2026, 10:15 AM

SID Score

6.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.24B
P/E ratio
42.01
Dividend yield
0.00%
52-week range
$16.10 – $33.07
Volume
807.73K
Avg. volume
1.58M

Price performance · PGNY

PGNY price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

PGNY closed at $29.19 after 20 trading sessions, up 12.88% for the selected period.

Last close
$29.19
Period change
+12.88%
Period low
$25.86
Period high
$29.19
Daily close
View OHLC price history
PGNY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$28.66$29.22$28.30$29.19807.73K
Oct 29, 2026$28.03$28.58$28.03$28.40657.47K
Oct 28, 2026$27.55$28.425$27.55$27.87543.2K
Oct 27, 2026$28.10$28.34$27.61$27.72923.76K
Oct 26, 2026$28.97$29.25$28.12$28.13650.93K
Oct 23, 2026$29.06$29.11$28.80$28.97565.86K
Oct 22, 2026$28.59$29.24$28.47$29.12744.61K
Oct 21, 2026$28.55$28.74$28.26$28.44712.71K
Oct 20, 2026$28.03$28.95$28.03$28.581.23M
Oct 19, 2026$26.77$27.86$26.7501$27.84782.04K
Oct 16, 2026$27.65$27.78$26.74$26.86919.57K
Oct 15, 2026$27.77$28.41$27.43$27.4551.06M
Oct 14, 2026$27.26$28.055$27.26$27.84774.08K
Oct 13, 2026$28.22$28.82$27.26$27.391.06M
Oct 12, 2026$27.88$28.17$27.64$28.03825.99K
Oct 9, 2026$27.895$28.24$27.635$27.93694.55K
Oct 8, 2026$27.51$28.00$26.85$27.831.7M
Oct 7, 2026$25.81$28.32$25.81$27.552.26M
Oct 6, 2026$25.86$26.24$25.56$25.91868.32K
Oct 5, 2026$25.25$25.92$25.01$25.861.05M

Latest PGNY news

The latest Smart Investors Daily articles mentioning PGNY.

Stock researchCompany · Overview

PGNY research

Overview

Company profile and research snapshot.

Company profile

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$28.50
Implied upside
—
Analysts
16
PGNY recent ratings
DateFirmRatingTarget
Sep 30, 2026Wells FargoOverweight—
Sep 8, 2026CitizensMarket Outperform—
Aug 21, 2026JP MorganNeutral—
Aug 20, 2026Wells FargoOverweight—
Aug 13, 2026Truist SecuritiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 26, 2026

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

More than 70% of members in the study reported symptom improvement, with the greatest gains among those receiving both personalized coaching and menopause-trained provider careNEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced findings from a new clinical outcomes study showing significant improvements in menopause symptoms among members receiving care through its Menopause and Midlife program

Yahoo · Oct 21, 2026

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2026, after the close of the market on Wednesday, November 4, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the Un

Yahoo · Oct 19, 2026

3 Value Stocks Walking a Fine Line

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By